TipRanks
Eastwood Bio-Medical Canada Inc (TSE:EBM)
:EBM
Canadian Market
EBM
Eastwood Bio-Medical Canada
RESEARCH TOOLSreports
Want to see TSE:EBM full AI Analyst Report?

Eastwood Bio-Medical Canada (EBM) Ratios

5 Followers

Eastwood Bio-Medical Canada Ratios

TSE:EBM's free cash flow for Q3 2026 was C$0.48. For the 2026 fiscal year, TSE:EBM's free cash flow was decreased by C$ and operating cash flow was C$-0.44. See a summary of the company’s cash flow.
Ratios
TTM
Jan 26Jan 25Oct 23Oct 22
Liquidity Ratios
Current Ratio
 0.05 0.02 0.03 0.11 0.12
Quick Ratio
 0.05 0.02 0.03 0.11 0.12
Cash Ratio
 <0.01 <0.01 0.00 0.01 0.05
Solvency Ratio
 -0.10 -0.16 -0.22 -0.33 -0.06
Operating Cash Flow Ratio
 >-0.01 0.01 >-0.01 -0.01 >-0.01
Short-Term Operating Cash Flow Coverage
 -0.15 0.25 -0.19 -0.73 -0.16
Net Current Asset Value
C$ -1.94MC$ -1.82MC$ -1.53MC$ -1.18MC$ -777.27K
Leverage Ratios
Debt-to-Assets Ratio
 0.25 0.36 0.29 0.05 0.11
Debt-to-Equity Ratio
 -0.04 -0.05 -0.06 -0.03 -0.21
Debt-to-Capital Ratio
 -0.04 -0.05 -0.07 -0.03 -0.27
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 -0.13
Financial Leverage Ratio
 -0.14 -0.13 -0.21 -0.58 -1.99
Debt Service Coverage Ratio
 -3.19 -3.56 -3.98 -8.01 -1.13
Interest Coverage Ratio
 -24.22 -39.38 -69.63 -17.97 -12.03
Debt to Market Cap
 <0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 -0.25 -0.19 -0.23 -0.01 -0.69
Profitability Margins
Gross Profit Margin
66.27%64.70%64.72%50.75%69.45%
EBIT Margin
-33.24%-45.35%-64.04%-59.73%-10.71%
EBITDA Margin
-29.38%-39.60%-48.72%-47.31%-2.49%
Operating Profit Margin
-33.24%-45.35%-62.34%-58.30%-9.91%
Pretax Profit Margin
-28.51%-42.55%-64.93%-62.98%-11.53%
Net Profit Margin
-28.51%-42.55%-64.93%-62.98%-12.35%
Continuous Operations Profit Margin
-28.51%-42.55%-64.93%-62.98%-11.53%
Net Income Per EBT
100.00%100.00%100.00%100.00%107.14%
EBT Per EBIT
85.78%93.82%104.15%108.01%116.40%
Return on Assets (ROA)
-90.12%-152.11%-166.20%-111.75%-27.47%
Return on Equity (ROE)
13.66%20.42%35.16%65.01%54.58%
Return on Capital Employed (ROCE)
15.13%21.77%33.76%60.19%49.63%
Return on Invested Capital (ROIC)
15.69%22.86%35.96%61.88%55.51%
Return on Tangible Assets
-90.12%-152.11%-166.20%-111.75%-27.47%
Earnings Yield
-0.17%-0.69%-0.68%-0.99%-0.19%
Efficiency Ratios
Receivables Turnover
 8.26 53.49 16.37 10.48 89.09
Payables Turnover
 5.68 3.27 3.28 4.20 6.58
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 5.26 4.21 3.04 2.57 2.91
Asset Turnover
 3.16 3.57 2.56 1.77 2.22
Working Capital Turnover Ratio
 -0.43 -0.47 -0.52 -0.90 -1.75
Cash Conversion Cycle
 -20.11 -104.86 -88.90 -52.06 -51.35
Days of Sales Outstanding
 44.19 6.82 22.29 34.82 4.10
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 64.30 111.68 111.20 86.88 55.45
Operating Cycle
 44.19 6.82 22.29 34.82 4.10
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 <0.01 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
 >-0.01 <0.01 >-0.01 >-0.01 >-0.01
CapEx Per Share
 <0.01 <0.01 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.70
Dividend Paid and CapEx Coverage Ratio
 -1.18K 6.43K 0.00 -8.44K -1.43
Capital Expenditure Coverage Ratio
 -1.18K 6.43K 0.00 -8.44K -1.43
Operating Cash Flow Coverage Ratio
 -0.15 0.25 -0.19 -0.73 -0.07
Operating Cash Flow to Sales Ratio
 -0.01 0.02 -0.02 -0.02 >-0.01
Free Cash Flow Yield
>-0.01%0.04%-0.02%-0.03%>-0.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -625.81 -145.83 -148.09 -100.82 -536.21
Price-to-Sales (P/S) Ratio
 164.56 61.66 96.16 63.49 66.25
Price-to-Book (P/B) Ratio
 -74.90 -29.59 -52.06 -65.54 -292.69
Price-to-Free Cash Flow (P/FCF) Ratio
 -14.19K 2.50K -4.44K -3.26K -11.80K
Price-to-Operating Cash Flow Ratio
 -14.17K 2.50K -4.44K -3.26K -20.05K
Price-to-Earnings Growth (PEG) Ratio
 -9.69 5.35 9.00 -0.41 7.23
Price-to-Fair Value
 -74.90 -29.59 -52.06 -65.54 -292.69
Enterprise Value Multiple
 -560.35 -155.88 -197.60 -134.23 -2.66K
Enterprise Value
 133.70M 48.28M 67.59M 55.11M 86.13M
EV to EBITDA
 -560.35 -155.88 -197.60 -134.23 -2.66K
EV to Sales
 164.63 61.73 96.27 63.50 66.27
EV to Free Cash Flow
 -14.19K 2.50K -4.44K -3.26K -11.80K
EV to Operating Cash Flow
 -14.18K 2.50K -4.44K -3.26K -20.06K
Tangible Book Value Per Share
 -0.03 -0.02 -0.02 -0.01 >-0.01
Shareholders’ Equity Per Share
 -0.03 -0.02 -0.02 -0.01 >-0.01
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 -0.07
Revenue Per Share
 0.01 0.01 0.01 0.01 0.02
Net Income Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Tax Burden
 1.00 1.00 1.00 1.00 1.07
Interest Burden
 0.86 0.94 1.01 1.05 1.08
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.87 1.10 0.75 0.77 0.71
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.04 -0.06 0.03 0.03 0.03
Currency in CAD